In today’s fast-moving and unpredictable market, companies face mounting pressure to produce efficiently while minimizing capital exposure. This webinar explores how asset-light manufacturing offers a practical path to increase flexibility, reduce infrastructure risk and accelerate market readiness. By partnering with a Contract Development and Manufacturing Organization (CDMO), companies can achieve capital efficiency, faster market entry and reduced risk, without the burden of owning production infrastructure.
Attendees will learn what “asset-light” truly represents, not only as a cost-efficient model, but as a strategic mindset that lets organizations focus on their core strengths while relying on expert partners for execution. The featured speakers will unpack why this approach is gaining traction: reducing exposure to supply chain weakness, improving production agility and strengthening innovation models. Real-world examples will show how companies have avoided major CapEx pitfalls, expanded capacity on demand and launched new products with minimal investment.
Attendees will also see how asset-light frameworks deliver flexibility, operational focus and built-in scalability. The featured speakers will also explore how dual-site manufacturing protects supply, how redundant capacity prevents seasonal congestion and how localized production shortens the path to market, all while supporting quality and compliance. The session also highlights integrated scientific and engineering resources that help partners innovate without building internal infrastructure.
Register for this webinar to learn how asset-light manufacturing enables greater flexibility, capital efficiency and operational focus.
Speaker
M. Scott Carpenter, Vice President, Marketing & Partner Innovation, Formulated Solutions
Scott Carpenter is the Vice President of Marketing & Partner Innovation at Formulated Solutions, a leading US contract developer and manufacturer specializing in topical OTC drugs, medical devices and advanced consumer healthcare products. Over his eight years at Formulated Solutions, Scott has helped companies develop breakthrough OTC drug concepts and successfully transfer products into the organization’s sites for high-quality, reliable and compliant production.
With more than 25 years of experience spanning Bayer, Merck and SC Johnson, Scott has led global innovation programs that have generated over $1B in retail sales. He holds more than 40 patents across packaging, delivery systems and consumer health technologies.
At Formulated Solutions, he drives strategic growth, brand visibility and innovation partnerships across aerosols, semisolids, liquids and novel dispensing systems, helping transform complex consumer concepts into scalable, FDA-compliant commercial solutions. Known for his thoughtful leadership style, customer-centric approach and passion for building asset-light strategies, Scott represents the company on the global stage and champions solutions that help partners bring breakthrough products to market faster, safer and smarter.
Who Should Attend?
This webinar will appeal to professionals in marketing, product development, operations and executive leadership seeking capital-efficient approaches to manufacturing and commercialization.
What You Will Learn
Attendees will gain insight into:
- How asset-light manufacturing accelerates market entry, increases flexibility and reduces risk through strategic CDMO partnerships
- Methods to redirect capital away from infrastructure and toward innovation, marketing and business expansion
- Real-world examples of scaling production, managing demand surges and strengthening supply reliability without heavy CapEx commitments
- How integrated scientific and engineering resources speed development, support compliance and maintain quality, without the need to build internal infrastructure
Xtalks Partner
Formulated Solutions
Formulated Solutions is a U.S.-based Contract Development and Manufacturing Organization specializing in advanced non-sterile, small molecule, topical, nasal, and liquid oral dose OTC drugs, medical devices, and consumer healthcare products. With industry-leading expertise across aerosols, semisolids, liquids, and innovative dispensing systems, the company helps partners transform complex ideas into high-quality, FDA-compliant commercial products.
Operating from two U.S. manufacturing sites with redundant capabilities, Formulated Solutions offers exceptional scalability, from tens of thousands to tens of millions of units, ensuring supply reliability even during seasonal spikes or unexpected market shifts. The organization combines strong regulatory support, deep scientific and engineering resources, and a proven track record of developing and improving formulas.
Known for smart, asset-light partnerships, Formulated Solutions enables customers to avoid large capital investments while accelerating development, strengthening quality, and improving speed to market. The company is trusted by top global healthcare brands for its innovation, technical strength, and unwavering commitment to consumer safety and product performance.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account